Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T6IM
|
|||
| Former ID |
DNCL002822
|
|||
| Drug Name |
Tetomilast
|
|||
| Synonyms |
Tetomilast; 145739-56-6; 6-(2-(3,4-Diethoxyphenyl)thiazol-4-yl)picolinic acid; OPC-6535; UNII-S6RXB5KF56; S6RXB5KF56; 2-(3,4-Diethoxyphenyl)-4-(2-carboxy-6-pyridyl)thiazole; 2-Pyridinecarboxylicacid, 6-[2-(3,4-diethoxyphenyl)-4-thiazolyl]-; 6-[2-(3,4-diethoxyphenyl)-1,3-thiazol-4-yl]pyridine-2-carboxylic acid; Tetomilast [INN]; 6-(2-(3,4-Diethoxyphenyl)-1,3-thiazol-4-yl)pyridine-2-carboxylic acid; OPC 6535; ACMC-1BW9F; AC1MHG07; SCHEMBL436663; GTPL9877; CHEMBL332750; CTK0H7037; OPC6535; DTXSID00163149
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Chronic obstructive pulmonary disease [ICD-11: CA22; ICD-10: J44, J44.9] | Phase 2 | [1] | |
| Company |
Otsuka America Pharmaceutical
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H18N2O4S
|
|||
| Canonical SMILES |
CCOC1=C(C=C(C=C1)C2=NC(=CS2)C3=NC(=CC=C3)C(=O)O)OCC
|
|||
| InChI |
1S/C19H18N2O4S/c1-3-24-16-9-8-12(10-17(16)25-4-2)18-21-15(11-26-18)13-6-5-7-14(20-13)19(22)23/h5-11H,3-4H2,1-2H3,(H,22,23)
|
|||
| InChIKey |
XDBHURGONHZNJF-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 145739-56-6
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00874497) Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.